Innovation
1 patent family — focus: Human necessities; filing pace active.
| Year | Filings |
|---|---|
| 2026 | 1 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Early-stage biopharma start-up developing small molecule therapeutics for neuropsychiatric diseases
1 patent family — focus: Human necessities; filing pace active.
| Year | Filings |
|---|---|
| 2026 | 1 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |